Lumican, a member of a class II family of small leucine-rich proteoglycans, is highly upregulated in different cancer types, especially pancreas, breast, and cervical cancer5–8, and affects the proliferation, migration, and adhesion of cancer cells through a variety of mechanisms4,9–13. This evidence concerns the gene LUM and cancer.